Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare Biotechnology

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > Nothing but up from here folks!!

View:

Post by TruthSeeker81 on Nov 16, 2021 6:13am

Nothing but up from here folks!!

https://www.globenewswire.com/news-release/2021/11/16/2335092/0/en/Revive-Therapeutics-Announces-Published-Research-Results-on-Bucillamine-as-Potential-Inhibitor-of-SARS-CoV-2-Infection-Delta-Variant.html

258

Comment

Comment by RandomGuy1 on Nov 16, 2021 8:07am

amazing news!

Comment

Comment by 1ottrunner on Nov 16, 2021 8:42am

I couldn't find a covid related study for Amifostine or Cysteamine so Buc is well in the lead at this time.

105

Comment

Comment by Trippedstocks on Nov 16, 2021 10:09am

I've been wondering for some time why they budgeted for a reformulation. They've been planning it since the last placement last Feb. Someone send this to CNN and all the media

104

Comment

Comment by RandomGuy1 on Nov 16, 2021 11:15am

Where did they mention the budgetin for reform.??

Comment

Comment by Trippedstocks on Nov 16, 2021 12:12pm

from Feb 25, 2021 MD&A (3) The Companys discovery and formulation development programs includes exploring novel uses of Bucillamine for infectious diseases, liver diseases, and other psychedelic compounds for various disorders in pre-clinical models. The Company is pursuing the development of a next generation formulation of Bucillamine. The $2,000,000 is anticipated to be allocated to cover ...more

129

Comment